From amsacrine to DACA (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide): Selectivity for topoisomerases I and II among acridine derivatives
- 30 April 1996
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 32 (4), 708-714
- https://doi.org/10.1016/0959-8049(95)00604-4
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Experimental solid tumour activity ofN-[2-(dimethylamino)ethyl]-acridine-4-carboxamideCancer Chemotherapy and Pharmacology, 1995
- Antagonistic effect of aclarubicin on camptothecin induced cytotoxicity: Role of topoisomerase IBiochemical Pharmacology, 1994
- Unusual dynamics of killing of cultured lewis lung cells by the DNA-intercalating antitumour agentN-[2-(dimethylamino)ethyl]acridine-4-carboxamideCancer Chemotherapy and Pharmacology, 1992
- Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungusBiochemistry, 1991
- Selectivity of N-[2-(Dimethylamino)ethyl]acridine-4-car☐amide towards Lewis lung carcinoma and human tumour cell lines in vitroEuropean Journal of Cancer and Clinical Oncology, 1989
- A Special Role for Amsacrine in the Treatment of Acute LeukemiaCancer Investigation, 1989
- Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamideJournal of Medicinal Chemistry, 1987
- Potential antitumor agents. 46. Structure-activity relationships for acridine monosubstituted derivatives of the antitumor agent N-[2-(dimethylamino)ethyl]-9-aminoacridine-4-carboxamideJournal of Medicinal Chemistry, 1986
- Potential antitumor agents. 35. Quantitative relationships between antitumor (L1210) potency and DNA binding for 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) analogsJournal of Medicinal Chemistry, 1981